Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Lucy writes song for her Father, Neuroendocrine Cancer patient
Neuroendocrine Cancer Patient Story
Name: Deborah Age: 60 Neuroendocrine Cancer Site: Primary to small bowel. Metastasis to liver. Deborah's story: I was diagnosed in February 2016 with small bowel Neuroendocrine Cancer with liver metastasis. For years I thought I was going through the menopause...
NEWS ALERT : MHRA : Co-codamol recall
The Medicines and Healthcare products Regulatory Agency (MHRA) is supporting a pharmacy/patient level Class 1 National Patient Safety Alert to recall Co-codamol 30/500 Effervescent Tablets (Batch number 1K10121). People who use Co-codamol, widely used for pain...